ReviewInfection and drug resistance2026
Strengthening One Health AMR Surveillance in Africa: From Cross-Sectoral Data to Policy Action.
Review in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) has emerged as one of the greatest threats to global health, with Africa bearing a disproportionate burden: an estimated 1.05 million deaths were associated with bacterial AMR and approximately 250,000 deaths were directly attributable to AMR in the WHO African Region in 2019 alone. This burden reflects high infectious disease prevalence, limited diagnostic capacity, weak antimicrobial stewardship, and fragmented surveillance systems. Given that resistant pathogens and resistance genes circulate across humans, animals, and the environment, effective surveillance requires a coordinated One Health approach. This narrative review synthesizes published literature (2015-2026) identified through PubMed, Scopus, Web of Science, and Google Scholar to assess the status of One Health AMR surveillance in Africa, examine progress across the human, animal, and environmental sectors, identify major implementation barriers, and propose strategic priorities for strengthening integrated surveillance systems. The evidence reviewed shows that participation in surveillance initiatives such as GLASS has expanded and laboratory capacity has improved in several countries; however, substantial gaps remain in veterinary and environmental surveillance, laboratory infrastructure, data interoperability, governance, workforce capacity, and sustainable financing. Fragmented information systems and limited cross-sectoral collaboration continue to impede timely detection of emerging resistance and evidence-informed policy action. Based on these findings, we recommend prioritizing integrated governance structures, strengthened laboratory networks, interoperable digital surveillance platforms, and sustainable domestic financing as foundational steps, with genomic technologies, wastewater surveillance, and regional collaboration serving as complementary priorities as feasibility and resources allow. Strengthening One Health surveillance will be critical for improving early detection of resistant pathogens, informing antimicrobial stewardship, supporting outbreak preparedness, and reducing the growing health and economic burden of AMR across Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.